A novel homozygous frameshift variant in the cellular retinaldehyde-binding protein 1 ( RLBP1 ) gene causes retinitis punctata albescens

Abstract

Background

Retinitis punctata albescens is a form of retinitis pigmentosa characterized by white fleck-like deposits in the fundus, in most cases caused by pathogenic variants in RLBP1 gene. The purpose of this work is to report the phenotypic and genotypic data of a patient with retinitis punctata albescens carrying a deletion in the RLBP1 gene.

Results

An 8-year-old Caucasian female has been complaining of nyctalopia for the last 2 years. No other ocular symptoms were present. No relevant past medical or familiar history was described. At clinical examination, the patient’s best-corrected visual acuity was 20/20 in both eyes. Anterior segment evaluation and intraocular pressure were normal in both eyes. At fundoscopy, multiple punctate whitish-yellow fleck-like lesions were observed in the proximity of temporal superior and inferior vascular arcades. Scotopic electroretinogram demonstrated severely reduced rod response, without improvement or recovery of rod system function after prolonged dark adaptation. Blood DNA samples of this patient and from her parents were screened for causal variants in RLBP1, RDH5, and PRPH2.

Conclusion

A probable pathogenic frameshift variant was identified in homozygosity in the RLBP1 gene with an autosomal recessive transmission as another cause of retinitis punctata albescens. This DNA variant will aid ongoing functional studies and add to our understanding of the molecular pathology about RLBP1-associated retinopathies.

Keywords

retinitis punctata albescens retinitis pigmentosa rod-cone dystrophies flecked retina spectrum

Get full access to this article

View all access options for this article.

References

Hamel

Dessalces

Meunier

Retinitis punctata albescens. In: Puech

De Laey

Holder

(eds) Inherited chorioretinal dystrophies. Berlin; Heidelberg: Springer, 2014, pp. 135–141.

Morimura

Berson

Dryja

TP.

Recessive mutations in the RLBP1 gene encoding cellular retinaldehyde-binding protein in a form of retinitis punctata albescens. Invest Ophthalmol Vis Sci 1999; 40(5): 1000–1004.

Skorczyk-Werner

Pawlowski

Michalczuk

, et al. Fundus albipunctatus: review of the literature and report of a novel RDH5 gene mutation affecting the invariant tyrosine (p.Tyr175Phe). J Appl Genet 2015; 56(3): 317–327.

Sparkes

Heinzmann

Goldflam

, et al. Assignment of the gene (RLBP1) for cellular retinaldehyde-binding protein (CRALBP) to human chromosome 15q26 and mouse chromosome 7. Genomics 1992; 12(1): 58–62.

Saari

Nawrot

Kennedy

, et al. Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron 2001; 29(3): 739–748.

Hajali

Fishman

Dryja

, et al. Diagnosis in a patient with fundus albipunctatus and atypical fundus changes. Doc Ophthalmol 2009; 118(3): 233–238.

Dessalces

Bocquet

Bourien

, et al. Early-onset foveal involvement in retinitis punctata albescens with mutations in RLBP1. JAMA Ophthalmol 2013; 131(10): 1314–1323.

Hipp

Zobor

Glockle

, et al. Phenotype variations of retinal dystrophies caused by mutations in the RLBP1 gene. Acta Ophthalmol 2015; 93(4): e281–e286.

Richards

Aziz

Bale

, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(5): 405–424.

10.

Holbrook

Neu-Yilik

Hentze

, et al. Nonsense-mediated decay approaches the clinic. Nat Genet 2004; 36(8): 801–808.

11.

Golovleva

Bhattacharya

, et al. Disease-causing mutations in the cellular retinaldehyde binding protein tighten and abolish ligand interactions. J Biol Chem 2003; 278(14): 12397–12402.